Eupraxia Pharmaceuticals (EPRX) Capital Expenditures (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Capital Expenditures of -$173,092 for the quarter ended Jun 30, 2026, compared with -$166,225 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Capital Expenditures (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eupraxia Pharmaceuticals' Capital Expenditures came in at -$753,723; for the year ended Dec 31, 2025, it was -$588,947.
- By year, Capital Expenditures came in at -$104,227 in the year ended Dec 31, 2024, -$73,377 in the year ended Dec 31, 2023 and -$235,550 in the year ended Dec 31, 2022.
- Five-year quarterly Capital Expenditures spans a low of -$326,953 in the quarter ended Mar 31, 2026 and a high of -$6,322 in the quarter ended Jun 30, 2023.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$326,953 (quarter ended Mar 31, 2026), -$193,301 (quarter ended Dec 31, 2025) and -$60,377 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Eupraxia Pharmaceuticals | 308.46 Mn | -133.60 Mn | - | -173,092.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -173,092.00 |
| Mar 31, 2026 | -326,953.00 |
| Dec 31, 2025 | 984,593.00 |
| Sep 30, 2025 | -60,377.00 |
| Jun 30, 2025 | -166,225.00 |
| Mar 31, 2025 | -169,044.00 |
| Dec 31, 2024 | 164,139.00 |
| Sep 30, 2024 | -42,275.00 |
| Jun 30, 2024 | -10,848.00 |
| Mar 31, 2024 | -6,789.00 |
| Dec 31, 2023 | 97,369.00 |
| Sep 30, 2023 | -9,602.00 |
| Jun 30, 2023 | -6,322.00 |
| Mar 31, 2023 | -8,068.00 |
API Access
Eupraxia Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();